Market revenue in 2023 | USD 1,014.3 million |
Market revenue in 2030 | USD 2,133.2 million |
Growth rate | 11.2% (CAGR from 2023 to 2030) |
Largest segment | Ph sensor |
Fastest growing segment | PH Sensor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PH Sensor, Oxygen Sensors, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meter & Sensors, Other Sensors |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corp, Alphabet Inc Class C, Booz Allen Hamilton Holding Corp Class A, Compagnie de Saint-Gobain SA, Parker Hannifin Corp, Dover Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single-use bioprocessing probes and sensors market will help companies and investors design strategic landscapes.
Ph sensor was the largest segment with a revenue share of 19.94% in 2023. Horizon Databook has segmented the U.S. single-use bioprocessing probes and sensors market based on ph sensor, oxygen sensors, pressure sensors, temperature sensors, conductivity sensors, flow meter & sensors, other sensors covering the revenue growth of each sub-segment from 2018 to 2030.
The substantial share of the U.S. in the regional market can be recognized mainly due to the presence of large-scale manufacturing facilities for biopharmaceuticals. The biopharmaceutical sector is considered the most R&D-intensive in the U.S. and its development is recognized as a high-impact factor in the industry.
Consequently, this can drive the adoption of single-use technologies in the coming years for a flexible and fast approach, thus, leading to significant revenue generation in the U.S. Furthermore, the U.S. FDA has predicted that each year it will be approving around 10 to 20 cell & gene therapy products by 2025 due to the current clinical success rates and promising product pipeline.
This can result in the rapid adoption of disposable containers and other equipment in the bioprocessing industry, which can help curb the demand-supply gap in the upcoming years. Moreover, many companies are involved in developing their manufacturing capabilities to support the increasing demand.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. single-use bioprocessing probes and sensors market , including forecasts for subscribers. This country databook contains high-level insights into U.S. single-use bioprocessing probes and sensors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account